Resona Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.4M Sell
191,920
-12,566
-6% -$1.05M 0.08% 224
2026
Q1
$16.4M Buy
204,486
+19,802
+11% +$1.63M 0.08% 227
2025
Q4
$15.8M Sell
184,684
-7,421
-4% -$609K 0.08% 230
2025
Q3
$14.9M Sell
192,105
-10,294
-5% -$804K 0.07% 251
2025
Q2
$15.8M Buy
202,399
+7,686
+4% +$573K 0.08% 244
2025
Q1
$14.1M Buy
194,713
+9,174
+5% +$657K 0.08% 232
2024
Q4
$13.8M Sell
185,539
-11,403
-6% -$798K 0.08% 225
2024
Q3
$13M Sell
196,942
-3,260
-2% -$237K 0.08% 248
2024
Q2
$18.5M Sell
200,202
-13,420
-6% -$1.19M 0.11% 169
2024
Q1
$20.4M Buy
+213,622
New +$17.9M 0.12% 166

Other funds holding EW

Resona Asset Management's EW Position: Q2 2026 in Review

Resona Asset Management reduced its Edwards Lifesciences (EW) stake by 6.1% in Q2 2026, selling an estimated $1.05M and leaving 191,920 shares worth $17.4M. The position accounts for 0.08% of the portfolio, ranked #224.

Resona Asset Management first reported a position in EW in Q1 2024 and has held it in 10 quarters since. The position peaked at $20.4M in Q1 2024. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Resona Asset Management held 191,920 shares of Edwards Lifesciences worth $17.4M as of Q2 2026.
  • Resona Asset Management sold 12,566 Edwards Lifesciences shares in Q2 2026, an estimated $1.05M.
  • Edwards Lifesciences made up 0.08% of Resona Asset Management's portfolio in Q2 2026, its #224 holding.
  • Resona Asset Management first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 10 quarters since.
  • Resona Asset Management's Edwards Lifesciences position peaked at $20.4M in Q1 2024.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.